Table 1.
Summary matrix showing all pairwise comparisons for treatment response.
| AML5 | 5.21 (2.53, 11.19) | 3.93 (2.46, 6.43) | 3.37 (1.41, 8.47) | 1.97 (0.6, 7.3) | 2.74 (1.57, 4.94) | 3.29 (1.58, 7.09) | 0.26 (0.13, 0.49) |
| 0.19 (0.09, 0.39) | AZL20_AML5 | 0.75 (0.31, 1.81) | 0.65 (0.2, 2.08) | 0.38 (0.09, 1.68) | 0.53 (0.2, 1.33) | 0.63 (0.22, 1.8) | 0.05 (0.02, 0.13) |
| 0.25 (0.16, 0.41) | 1.33 (0.55, 3.27) | CAN8_AML5 | 0.86 (0.32, 2.36) | 0.5 (0.14, 2.02) | 0.7 (0.33, 1.48) | 0.84 (0.34, 2.06) | 0.07 (0.03, 0.14) |
| 0.3 (0.12, 0.71) | 1.55 (0.48, 4.97) | 1.17 (0.42, 3.08) | FIM60_AML5 | 0.59 (0.13, 2.84) | 0.82 (0.28, 2.32) | 0.98 (0.3, 3.12) | 0.08 (0.03, 0.19) |
| 0.51 (0.14, 1.66) | 2.64 (0.6, 11.01) | 1.99 (0.5, 7.19) | 1.7 (0.35, 7.69) | LOS50_AML5 | 1.39 (0.33, 5.25) | 1.66 (0.37, 6.93) | 0.13 (0.03, 0.51) |
| 0.36 (0.2, 0.64) | 1.9 (0.75, 4.9) | 1.43 (0.68, 3.02) | 1.22 (0.43, 3.56) | 0.72 (0.19, 2.99) | OLM20_AML5 | 1.2 (0.47, 3.14) | 0.09 (0.04, 0.22) |
| 0.3 (0.14, 0.63) | 1.59 (0.56, 4.54) | 1.19 (0.49, 2.9) | 1.02 (0.32, 3.32) | 0.6 (0.14, 2.72) | 0.84 (0.32, 2.15) | TEL40_AML25 | 0.08 (0.03, 0.21) |
| 3.82 (2.02, 7.6) | 20.1 (7.59, 55.96) | 15.04 (7.25, 32.97) | 12.91 (5.33, 33.47) | 7.61 (1.95, 33.24) | 10.54 (4.48, 25.82) | 12.63 (4.69, 35.22) | PBO |
Abbreviations: AML, amlodipine; AZL, azilsartan; CAN, candesartan; FIM, fimasartan; OLM, olmesartan; TEL, telmisartan; LOS, losartan; PBO, placebo; CI, confidence intervals.